Skip to content

Sotera Health SHC Current maturities of long-term debt

Current maturities of long-term debt at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
Balchem logo
BalchemBCPC
Labcorp Holdings logo
Labcorp HoldingsLH

Other financials

Income statement

See full
Revenue$280.0M+10.0%
Gross profit$147.1M+8.6%
Operating income$87.1M-16.2%
Net income$26.6M+301%
EPS (diluted)$0.09+280%

Balance sheet

See full
Cash & equivalents$314.1M+3.2%
Total debt$2.3B-3.2%
Total equity$622.5M+50.3%
Total assets$3.2B+4.5%

Cash flow

See full
Operating cash flow$29.4M-47.0%
CapEx$46.2M+132%
Free cash flow-$16.7M-147%

Valuation

See full
Market cap$4.51B+23.4%
Enterprise value$6.47B+12.8%
P/E38.3×-109×
P/S3.8×+0.5×

Profitability

See full
Gross margin55.3%+0.1pp
Operating margin27%+0.7pp
Net margin9.9%+7.7pp
FCF margin8.1%

Returns & leverage

See full
Return on equity22.7%+16.8pp
Debt / equity3.6×-2.0×
Current ratio2.8×+0.4×

Where this comes from

Reported directly by Sotera Health in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityCurrent.

The official record: Sotera Health’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sotera Health's current maturities of long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sotera Health's current maturities of long-term debt?
Sotera Health (SHC) reported current maturities of long-term debt of $3.58M in Q1 2026.
How has Sotera Health's current maturities of long-term debt changed year-over-year?
Sotera Health's current maturities of long-term debt increased by 17.7% year-over-year, from $3.04M to $3.58M.
What is the long-term trend for Sotera Health's current maturities of long-term debt?
Over 5 years (2020 to 2025), Sotera Health's current maturities of long-term debt has grown at a 24.2% compound annual growth rate (CAGR), from $1.17M to $3.47M.